Adebayo Alonge

CoFounder/CEO - RxAll, Inc.From Toronto, Canada
Adebayo is a multi-award winning and renowned global pioneer of In-Situ drug checking using Deep tech in pharma. He co-founded RxAll™ which is a real time AI platform for drug quality checking, monitoring and reporting.Through, RxAll™, he aims to eliminate substandard drugs across the world. His career in pharma is driven by a passion to eradicate substandard drugs as he almost died as a child from a counterfeit medicine.He has led RxAll™ to achieve a multi-million dollar valuation in 2 years and ramp up 7-figure sales orders in its first year. He also led its market entry into Africa,SE Asia and the Americas. Adebayo holds a management degree from Yale and qualified as a pharmacist. He is due to begin studying for an MPA from Harvard.His other skills include digital marketing, full stack programming and coding neural networks using R, Python and TensorFlow.He recently led RxAll to win the 2019 Hello Tomorrow Grand Prize out of 4500 deepTech startups from 119 countries.He is committed to using and spreading the philosophy of using science and tech to solve social problems in the developing world in a manner that improves the lives of the poor and reduces inequality and the social injustices that come with it
Adebayo's Topics+ See the schedule


Techsauce Global Summit 2020
Join Us
Buy Ticket